Jupiter Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.3M Sell
762,713
-85,694
-10% -$3.97M 0.16% 157
2026
Q2
$36.6M Buy
+848,407
New +$46.1M 0.18% 139
2025
Q4
– Sell
-6,578
Closed -$642K – 417
2025
Q3
$642K Buy
+6,578
New +$681K 0.01% 369
2022
Q3
– Sell
-327,183
Closed -$12.2M – 539
2022
Q2
$12.2M Buy
327,183
+252,650
+339% +$10.3M 0.17% 160
2022
Q1
$3.3M Sell
74,533
-1,192,934
-94% -$51.7M 0.04% 307
2021
Q4
$54.5M Buy
+1,267,467
New +$53.3M 0.6% 39
2020
Q4
– Sell
-282,947
Closed -$10.8M – 593
2020
Q3
$10.8M Sell
282,947
-25,289
-8% -$974K 0.11% 202
2020
Q2
$10.8M Buy
+308,236
New +$11.1M 0.36% 75
2019
Q1
– Sell
-6,755
Closed -$239K – 245
2018
Q4
$239K Buy
+6,755
New +$245K 0.01% 219

Other funds holding BSX

Jupiter Asset Management's BSX Position: Q3 2026 in Review

Jupiter Asset Management reduced its Boston Scientific (BSX) stake by 10% in Q3 2026, selling an estimated $3.97M and leaving 762,713 shares worth $33.3M. The position accounts for 0.16% of the portfolio, ranked #157.

Jupiter Asset Management first reported a position in BSX in Q4 2018 and has held it in 9 quarters since. The position peaked at $54.5M in Q4 2021. 922 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Jupiter Asset Management held 762,713 shares of Boston Scientific worth $33.3M as of Q3 2026.
  • Jupiter Asset Management sold 85,694 Boston Scientific shares in Q3 2026, an estimated $3.97M.
  • Boston Scientific made up 0.16% of Jupiter Asset Management's portfolio in Q3 2026, its #157 holding.
  • Jupiter Asset Management first reported a position in Boston Scientific in Q4 2018 and has held it in 9 quarters since.
  • Jupiter Asset Management's Boston Scientific position peaked at $54.5M in Q4 2021.
  • 922 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Jupiter Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.